August 18, 2009 โ Medical conferencing solutions provider MultiSense Communications and medical imaging specialist Barco recently demonstrated the clinical benefits of today's telemedicine systems during a live open-heart surgery operation at the Imperial College Hospital in Hammersmith, U.K.
August 18. 2009 - Researchers in Finland have identified embolization treatment of cerebral artery aneurysms as an effective new treatment option for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. Results of the new study on stent-assisted coil embolization were published today in the online edition of Radiology.
August 18, 2009 โ Cardiva Medical Inc. recently received FDA clearance for its Cardiva Catalyst III, which the company says is the first drug-coated vascular closure device for the intervention cardiology market.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 18, 2009 - Cardiac magnetic resonance (CMR) represents a safe, noninvasive modality that frequently helps guide patient management, according to early findings from a multicenter registry published online Aug. 11 in the Journal of the American College of Cardiology.
August 17, 2009 โ Siemens Healthcare will showcase cath lab imaging and workflow enhancements with its hybrid Artis zeego system during the 2009 Transcatheter Cardiovascular Therapeutics Annual Conference (TCT) Sept. 21-25 in San Francisco.
August 17, 2009 - Reverse Medical Corporation announced that it has received U.S. FDA 510k clearance for its ReCruit Microcatheter, intended to retrieve intravascular foreign objects during interventional radiology procedures, including from the neurovasculature.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 17, 2009 โ The single largest factor for growth in the remote/home patient monitoring market is in cardiovascular disease (CD) in the United States, according to a new report from the healthcare market research firm Frost & Sullivan.
August 17, 2009 - SonoSite Inc., a specialist in hand-carried ultrasound for the point-of-care, announced that on Aug. 14 it completed the acquisition of CardioDynamics International Corp., a leader in impedance cardiography (ICG) for noninvasive hemodynamic assessment.
August 14, 2009 - Lantheus Medical Imaging will continue to allocate its Mo-99 supply to serve as many people as possible, said the company today in response to the statement issued by AECL regarding the extended shutdown of the NRU reactor Aug. 12.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 14, 2009 โ Philips is currently introducing its Xcelera R3.1 cardiology informatics system, which has new telecardiology capabilities to support clinical workflow and help provide faster sharing capabilities for cardiac patient information.
August 14, 2009 โ ZOLL Medical Corp. said today Basingstoke and North Hampshire Hospital in Hampshire, United Kingdom, is the first hospital to install the AutoPulse Noninvasive Cardiac Support Pump in the cardiac catheterization laboratory in the U.K.
August 14, 2009 โ Unity Health System-Park Ridge in Rochester, N.Y., upgraded its OB-Windows systems with two OBLinks, providing instant, electronic transmission of patient data from ultrasound systems to Digisonics OB-View/OB-Windows systems eliminating human input error and increasing efficiency.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 13, 2009 - The Canadian Prime Minister Stephen Harper expressed disappointment with reports from the Atomic Energy of Canada Ltd. (AECL) that the aging nuclear reactor at Chalk River, Ontario, which produces most of the medical isotopes for Canada and the United States, will not be back up and running until the spring of 2010.
August 13, 2009 โ Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed to evaluate the safety and effectiveness of the company's XIENCE V Everolimus-Eluting Coronary Stent System in a real-world clinical setting out to five years.
August, 13, 2009 โ Atherotech Inc. this week added two new cardiometabolic tests โ the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early, sensitive marker for chronic kidney disease.